全文获取类型
收费全文 | 10801篇 |
免费 | 734篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 62篇 |
儿科学 | 247篇 |
妇产科学 | 281篇 |
基础医学 | 1538篇 |
口腔科学 | 396篇 |
临床医学 | 991篇 |
内科学 | 2214篇 |
皮肤病学 | 195篇 |
神经病学 | 1326篇 |
特种医学 | 321篇 |
外科学 | 1252篇 |
综合类 | 25篇 |
现状与发展 | 1篇 |
一般理论 | 8篇 |
预防医学 | 967篇 |
眼科学 | 121篇 |
药学 | 711篇 |
中国医学 | 49篇 |
肿瘤学 | 894篇 |
出版年
2024年 | 11篇 |
2023年 | 115篇 |
2022年 | 198篇 |
2021年 | 424篇 |
2020年 | 257篇 |
2019年 | 393篇 |
2018年 | 429篇 |
2017年 | 340篇 |
2016年 | 394篇 |
2015年 | 372篇 |
2014年 | 465篇 |
2013年 | 605篇 |
2012年 | 874篇 |
2011年 | 851篇 |
2010年 | 455篇 |
2009年 | 431篇 |
2008年 | 679篇 |
2007年 | 643篇 |
2006年 | 634篇 |
2005年 | 577篇 |
2004年 | 541篇 |
2003年 | 476篇 |
2002年 | 386篇 |
2001年 | 116篇 |
2000年 | 86篇 |
1999年 | 111篇 |
1998年 | 59篇 |
1997年 | 70篇 |
1996年 | 39篇 |
1995年 | 34篇 |
1994年 | 31篇 |
1993年 | 24篇 |
1992年 | 56篇 |
1991年 | 66篇 |
1990年 | 35篇 |
1989年 | 42篇 |
1988年 | 36篇 |
1987年 | 35篇 |
1986年 | 27篇 |
1985年 | 27篇 |
1984年 | 25篇 |
1983年 | 8篇 |
1982年 | 15篇 |
1981年 | 9篇 |
1980年 | 8篇 |
1979年 | 11篇 |
1977年 | 11篇 |
1974年 | 13篇 |
1973年 | 10篇 |
1971年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
951.
Nina Egger D.Sc. Alexander Konnopka M.D. Manfred E. Beutel M.D. Stephan Herpertz M.D. Wolfgang Hiller Ph.D. Juergen Hoyer Ph.D. Simone Salzer D.Sc. Ulrich Stangier D.Sc. Bernhard Strauss Ph.D. Ulrike Willutzki Ph.D. Joerg Wiltink M.D. Eric Leibing D.Sc. Falk Leichsenring D.Sc. Hans-Helmut König M.D. 《Depression and anxiety》2016,33(12):1114-1122
952.
A. Lauro A.D. Pinna E. Tossani V. Stanghellini M. Manno G. Caio L. Golfieri C. Zanfi N. Cautero A. Bagni U. Volta M. Di Simone L. Pironi R.F. Cogliandro M. Serra A. Venturoli S. Grandi R. De Giorgio 《Transplantation proceedings》2018,50(1):226-233
Background
Clinical and psychosocial outcomes of a multimodal surgical approach for chronic intestinal pseudo-obstruction were analyzed in 24 patients who were followed over a 2- to 12-year period in a single center after surgery or intestinal/multivisceral transplant (CTx).Methods
The main reasons for surgery were sub-occlusion in surgery and parenteral nutrition–related irreversible complications with chronic intestinal failure in CTx.Results
At the end of follow-up (February 2015), 45.5% of CTx patients were alive: after transplantation, improvement in intestinal function was observed including a tendency toward recovery of oral diet (81.8%) with reduced parenteral nutrition support (36.4%) in the face of significant mortality rates and financial costs (mean, 202.000 euros), frequent hospitalization (mean, 8.8/re-admissions/patient), as well as limited effects on pain or physical wellness.Conclusions
Through psychological tests, transplant recipients perceived a significant improvement of mental health and emotional state, showing that emotional factors were more affected than were functional/cognitive impairment and social interaction. 相似文献953.
Sonja Chiappetta Hannah M. Schaack Bettina Wölnerhannsen Christine Stier Simone Squillante Rudolf A. Weiner 《Obesity surgery》2018,28(10):3028-3040
Background
Obesity and metabolic surgery is known to improve chronic inflammatory status. Whether improvement is related to anatomical changes or weight loss is still to debate.Objective
The aim of this clinical trial is to compare the different bariatric procedures sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and One-anastomosis gastric bypass (OAGB), pertaining to their effects on inflammation markers.Methods
Patients who underwent SG, RYGB, or OAGB as a primary treatment for severe obesity were included. The data collected preoperatively (T0) and 1, 3, and 6 (T6) months after surgery included gender, weight, comorbidities and toxic habits at baseline, body mass index (BMI), waist circumference, total body weight loss in % (TBWL), leukocyte count in ×?103/μl, C-reactive protein (CRP) in mg/l, HbA1c in %, aspartate transaminase in U/l, alanine transaminase in U/l, gamma-glutamyltransferase in U/l, bilirubin in mg/dl, cholesterol in mg/dl, and triglycerides in mg/dl.Results
Four hundred sixty-eight patients were included. Drop-out rate was 25.8% at T6. Preoperatively the mean value of leukocytes and CRP was 7.4?×?103/μl?±?2 and 10.5 mg/l?±?8.1. At T6, mean value of leukocytes and CRP was 7.1?×?103/μl?±?1.9 (p?=?0.075) and 7.2 mg/l?±?9.5 (p?<?0.001). TBWL % at T6 was 24.2?±?7.6 in the SG, 25.8?±?5.9 in the RYGB and 25.5?±?4.6 in the OAGB group. Comparing SG, RYGB, and OAGB in relation to leukocyte count and CRP no significant difference was seen between the groups.Conclusion
CRP but not leukocyte count decreased after all three bariatric procedures but without any significance between the three groups. Surgically induced weight loss and not anatomical changes might play an important role for improvement in chronic inflammation.Trial Registration
The National Clinical Trials number was NCT02697695 (https://clinicaltrials.gov/ct2/show/NCT02697695).954.
Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis 总被引:3,自引:0,他引:3
C De Simone L Baldinelli M Ferrazzi S De Santis L Pugnaloni F Sorice 《The Journal of antimicrobial chemotherapy》1986,17(6):811-814
Several new quinolone derivatives were investigated for their influence on human lymphocyte blastogenesis and gamma-interferon production following concanavalin A stimulation. All the antimicrobials induced inhibition of lymphocyte DNA synthesis. The gamma-interferon measurements showed that nalidixic acid and norfloxacin have a negative influence on lymphokine production and release. 相似文献
955.
The requirements of growth and organ development create a challenge in nutrition management for the pediatric patient. The stress of critical illness further complicates the delivery of adequate nutrients. Enteral feeding has several advantages over parenteral nutrition (PN), which include preservation of the gastrointestinal mucosa and decreasing the occurrence of sepsis related to bacterial translocation. Although feeding through the gastrointestinal tract is the preferred route for nutritional management, there are specific instances when PN as adjunctive or sole therapy is necessary to meet nutritional needs. With meticulous attention to fluid, caloric, protein, and fat requirements along with monitoring the metabolic status of the patient, it is possible to provide full nutritional support for the critically ill child within 24 to 48 hours of hospital admission. 相似文献
956.
957.
958.
Schauer U Stemberg F Rieger CH Borte M Schubert S Riedel F Herz U Renz H Wick M Carr-Smith HD Bradwell AR Herzog W 《Clinical chemistry》2003,49(11):1924-1929
BACKGROUND: There is currently no international reference preparation for IgG subclass (IgGSc) quantification. This situation has led to calibration differences among assays and a variety of reference interval values with consequential difficulties in comparing results. We therefore evaluated IgGSc concentrations in Certified Reference Material 470 (CRM 470). METHODS: Pure, polyclonal IgG1, -2, -3, and -4 were prepared from a large serum pool for use as primary standards. The IgG mass in each preparation was calculated from amino-acid analysis data. IgGSc concentrations were assessed in CRM 470 by nephelometry with modern analytical techniques, using these reference preparations. Subsequently, IgGSc concentrations were measured in 380 healthy individuals (250 males and 130 females), and age-dependent reference intervals were established. RESULTS: IgGSc concentrations in CRM 470 were as follows: IgG1, 5028 mg/L; IgG2, 3418 mg/L; IgG3, 579 mg/L, and IgG4, 381 mg/L, with a total IgG concentration of 9406 mg/L, 2.83% below the certified total IgG value of 9680 mg/L. Age-dependent percentile curves for the four IgGSc were constructed using a Box-Cox transformation. Maximum median values were as follows: IgG1, 6.02 g/L at 11 years; IgG2, 3.45 g/L at 31 years; IgG3, 0.63 g/L at 17 years; and IgG4, 0.48 g/L at 14 years. No significant sex-related differences were observed. CONCLUSIONS: The correlation between the summation of individual IgGSc and separate measurements of total IgG concentrations was good and supports the accuracy of the results. The results are based on The Binding Site assays and should not be considered appropriate for other assays unless so demonstrated. 相似文献
959.
960.
Hans-Dirk?Düngen Svetlana?Apostolovi? Simone?Inkrot Elvis?Tahirovi? Florian?Krackhardt Milan?Pavlovi? Biljana?Putnikovi? Mitja?Lain??ak G?tz?Gelbrich Frank?Edelmann Rolf?Wachter Thomas?Eschenhagen Finn?Waagstein Ferenc?Follath Mathias?Rauchhaus Wilhelm?Haverkamp Karl-Josef?Osterziel Rainer?Dietz 《Clinical research in cardiology》2008,97(9):578-586
Background Chronic heart failure (CHF) is a widespread disease with severe quality of life impairment and a poor prognosis. Beta-blockers
are the mainstay of CHF therapy; yet they are under-prescribed and under-dosed in clinical practice. This is particularly
evident in elderly patients, which may be due to a fear of side-effects or intolerance. Beta-blockers have further not been
adequately tested in patients with diastolic CHF, which is particularly common in elderly patients. Finally, comparative data
on the use of different beta-blockers in patients with CHF is scarce.
Aim To compare the tolerance of bisoprolol and carvedilol in elderly patients with CHF.
Methods CIBIS-ELD is an investigator-initiated, multi-centre, 1:1 randomised, double-blind, phase III trial comparing bisoprolol and
carvedilol in patients ≥65 years with systolic or diastolic CHF. Recruitment started in April 2005 and is anticipated to be
completed by April 2008 with at least 800 patients enrolled.
Perspective This is the first large scale head to head beta-blockers trial in an elderly population with CHF. Besides determining which
of two standard beta-blockers is best tolerated in elderly patients with systolic or diastolic CHF, we expect to gain further
insight into the treatment of the particular population of patients with diastolic CHF.
This trial was supported by the Competence Network of Heart Failure funded by the Federal Ministry of Education and Research
(BMBF, project number 01GI0205) and is registered with number ISRCTN34827306 at . 相似文献